Comparable stake leader
Janus Henderson Group Ltd.
SEC ownership of Invivyd, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001832038.
Disclosed value leader
Adimab, LLC
Comparable rows
50/50
Latest evidence
30 Jun 2026
- Public ticker
- IVVD on Nasdaq
- Parsed ownership sources
-
13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Janus Henderson Group Ltd.
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Janus Henderson Group Ltd.
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001832038
- Issuer location
- New Haven, CT
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Invivyd, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Janus Henderson Group Ltd.
Disclosed value leader
Adimab, LLC
Comparable rows
50/50
Latest evidence
30 Jun 2026
13D/G
3/4/5
13F
Lead comparable stake: 12%
13D/G row: Janus Henderson Group Ltd.
Showing 1-8 of 50 holder rows.
Quick read
Janus Henderson Group Ltd. leads the comparable SEC ownership view at 12%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Janus Henderson Group Ltd.'s linked filing trail.
Comparable ownership
Top 5
Janus Henderson Group Ltd.
12%
BIOTECHNOLOGY VALUE FUND L P
10%
Adimab, LLC
7.3%
RA CAPITAL MANAGEMENT, L.P.
7%
MAVERICK CAPITAL LTD
6.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Janus Henderson Group Ltd. |
13D/G
JANUS HENDERSON GROUP PLC
|
12%
|
$27,921,385
25,383,077 shares
|
+$1,222,450 | 30 Sep 2025 |
| BIOTECHNOLOGY VALUE FUND L P |
13D/G
BVF PARTNERS L P/IL
|
10%
|
$23,657,461
29,571,826 shares
|
+$3,237,461 | 30 Jun 2026 |
| Adimab, LLC |
3/4/5
13D/G
10%+ Owner
|
7.3%
from 13D/G
|
$85,667,229
21,687,906 shares
|
— | 19 Jan 2024 |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
|
7%
|
$36,709,000
21,342,442 shares
|
-$12,925,398 | 31 Mar 2026 |
| MAVERICK CAPITAL LTD |
13D/G
13F
Company
|
6.7%
|
$47,806,701
18,970,913 shares
|
+$22,029,323 | 31 Dec 2025 |
| PERCEPTIVE ADVISORS LLC |
13F
13D/G
Company
|
6.3%
from 13D/G
|
$16,131,231
18,490,636 shares
|
— | 30 Jun 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
5.5%
from 13D/G
|
$14,076,073
16,134,885 shares
|
— | 30 Jun 2026 |
| MITHRIL II LP |
3/4/5
13D/G
Other*, 10%+ Owner
|
4.8%
from 13D/G
|
$44,404,241
11,241,580 shares
|
— | 28 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$500,235.
Buys
$125,000
Insiders: 1
Sells
$625,235
Insiders: 5
Net
-$500,235
Shares: -570,947
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 50,000
Shares: 620,947
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 228,024 | $0 | $177,089 | -$177,089 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 227,172 | $0 | $354,232 | -$354,232 |
| 9-12 | 50,000 | 165,751 | $125,000 | $93,915 | +$31,085 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 39 reporting-owner rows connected to Invivyd, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
39
Largest Forms 3/4/5 holder
Adimab, LLC
Net 12M change
-$406,321
Latest report
15 Aug 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Adimab, LLC | 10%+ Owner | $85,667,229 | Filing P/S | 19 Jan 2024 | ||
| MITHRIL II LP | Other*, 10%+ Owner | $44,404,241 | Mixed | 28 Mar 2022 | ||
| Redmile Group, LLC | 10%+ Owner | $13,394,292 | Mixed | 10 Aug 2021 | ||
| Rene Russo | Director | $7,841,915 | Mixed | 05 Aug 2021 | ||
| Ajay Royan | Director | $5,008,124 | Mixed | 19 May 2026 | ||
| Cox Christopher T. | Other* | $2,685,297 | Mixed | 28 Mar 2022 | ||
| Polaris Venture Partners V, L.P. | Other* | $1,965,757 | Mixed | 28 Mar 2022 | ||
| Terrance McGuire | Director | $1,366,240 | Filing P/S | 19 May 2026 | ||
| Jill Andersen | Chief Legal Officer, Secretary | $462,379 | -$158,362 | -26% | Mixed | 15 Aug 2026 |
| Timothy Edward Lee | Chief Commercial Officer | $284,475 | -$95,021 | -25% | Mixed | 15 Aug 2026 |
| Robert D. Allen III | Chief Scientific Officer | $284,331 | -$87,896 | -24% | Mixed | 15 Aug 2026 |
| William E. Duke | Chief Financial Officer | $276,046 | -$95,021 | -26% | Mixed | 15 Aug 2026 |
| Julie Green | Chief Human Resources Officer | $276,046 | -$95,021 | -26% | Mixed | 15 Aug 2026 |
| Kevin F. Mclaughlin | Director | $125,000 | +$125,000 | +100% | Filing P/S | 19 May 2026 |
| Sara Cotter | Director | $3,950 | Mixed | 21 May 2024 | ||
| Howard Mayer | Director | Mixed | 22 Jun 2022 | |||
| Jane Pritchett Henderson | Chief Financial Officer | Mixed | 30 Jan 2022 | |||
| Elham Hershberger | Chief Development Officer | Mixed | 30 Jan 2022 | |||
| Tillman U. Gerngross | Chief Executive Officer, Director, 10%+ Owner | Mixed | 30 Jan 2022 | |||
| Ellen R. Marram | Director | Mixed | 19 Nov 2021 |
Recent insider transactions for Invivyd, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Timothy Edward Lee | IVVD | Common Stock | Sale | -9.34% | $15,530 | $0.8429 | -18,425 | 178,937 | 18 Aug 2026 | Direct |
| Julie Green | IVVD | Common Stock | Sale | -9.83% | $15,530 | $0.8429 | -18,425 | 168,937 | 18 Aug 2026 | Direct |
| William E. Duke | IVVD | Common Stock | Sale | -9.83% | $15,530 | $0.8429 | -18,425 | 168,937 | 18 Aug 2026 | Direct |
| Jill Andersen | IVVD | Common Stock | Sale | -9.76% | $25,882 | $0.8429 | -30,706 | 283,774 | 18 Aug 2026 | Direct |
| Robert D. Allen III | IVVD | Common Stock | Sale | -8.7% | $14,366 | $0.8429 | -17,043 | 178,765 | 18 Aug 2026 | Direct |
| Timothy Edward Lee | IVVD | Common Stock | Sale | -10.2% | $16,140 | $0.7220 | -22,355 | 197,362 | 17 Aug 2026 | Direct |
| Julie Green | IVVD | Common Stock | Sale | -10.7% | $16,140 | $0.7220 | -22,355 | 187,362 | 17 Aug 2026 | Direct |
| William E. Duke | IVVD | Common Stock | Sale | -10.7% | $16,140 | $0.7220 | -22,355 | 187,362 | 17 Aug 2026 | Direct |
| Jill Andersen | IVVD | Common Stock | Sale | -10.6% | $26,899 | $0.7220 | -37,256 | 314,480 | 17 Aug 2026 | Direct |
| Robert D. Allen III | IVVD | Common Stock | Sale | -9.55% | $14,930 | $0.7220 | -20,679 | 195,808 | 17 Aug 2026 | Direct |
| Timothy Edward Lee | IVVD | Common Stock | Options Exercise | 86.6% | 102,000 | 219,717 | 15 Aug 2026 | Direct | ||
| Timothy Edward Lee | IVVD | Restricted Stock Units | Options Exercise | -100% | -102,000 | 0 | 15 Aug 2026 | Direct | ||
| Julie Green | IVVD | Common Stock | Options Exercise | 94.7% | 102,000 | 209,717 | 15 Aug 2026 | Direct | ||
| Julie Green | IVVD | Restricted Stock Units | Options Exercise | -100% | -102,000 | 0 | 15 Aug 2026 | Direct | ||
| William E. Duke | IVVD | Common Stock | Options Exercise | 94.7% | 102,000 | 209,717 | 15 Aug 2026 | Direct | ||
| William E. Duke | IVVD | Restricted Stock Units | Options Exercise | -100% | -102,000 | 0 | 15 Aug 2026 | Direct | ||
| Jill Andersen | IVVD | Common Stock | Options Exercise | 93.5% | 170,000 | 351,736 | 15 Aug 2026 | Direct | ||
| Jill Andersen | IVVD | Restricted Stock Units | Options Exercise | -100% | -170,000 | 0 | 15 Aug 2026 | Direct | ||
| Robert D. Allen III | IVVD | Common Stock | Options Exercise | 89.1% | 102,000 | 216,487 | 15 Aug 2026 | Direct | ||
| Robert D. Allen III | IVVD | Restricted Stock Units | Options Exercise | -100% | -102,000 | 0 | 15 Aug 2026 | Direct | ||
| Michael Mina | IVVD | Stock Option (Right to Buy) | Award | 1,125,000 | 1,125,000 | 31 Jul 2026 | Direct | |||
| Ajay Royan | IVVD | Stock Option (Right to Buy) | Award | 50,000 | 50,000 | 19 May 2026 | Direct | |||
| Kevin F. McLaughlin | IVVD | Stock Option (Right to Buy) | Award | 50,000 | 50,000 | 19 May 2026 | Direct | |||
| Terrance McGuire | IVVD | Stock Option (Right to Buy) | Award | 50,000 | 50,000 | 19 May 2026 | Direct | |||
| Elia Marc | IVVD | Stock Option (Right to Buy) | Award | 50,000 | 50,000 | 19 May 2026 | Direct | |||
| Marc Elia | IVVD | Stock Option (Right to Buy) | Award | 50,000 | 50,000 | 19 May 2026 | Direct | |||
| Paul Bolno | IVVD | Stock Option (Right to Buy) | Award | 32,876 | 32,876 | 19 May 2026 | Direct | |||
| Tamsin Berry | IVVD | Stock Option (Right to Buy) | Award | 50,000 | 50,000 | 19 May 2026 | Direct | |||
| Robert D. Allen III | IVVD | Common Stock | Sale | -14.5% | $30,597 | $1.58 | -19,392 | 114,487 | 18 Feb 2026 | Direct |
| Julie Green | IVVD | Common Stock | Sale | -16.3% | $33,077 | $1.58 | -20,964 | 107,717 | 18 Feb 2026 | Direct |
| William E. Duke | IVVD | Common Stock | Sale | -16.3% | $33,077 | $1.58 | -20,964 | 107,717 | 18 Feb 2026 | Direct |
| Timothy Edward Lee | IVVD | Common Stock | Sale | -15.1% | $33,077 | $1.58 | -20,964 | 117,717 | 18 Feb 2026 | Direct |
| Jill Andersen | IVVD | Common Stock | Sale | -16.1% | $55,127 | $1.58 | -34,939 | 181,736 | 18 Feb 2026 | Direct |
| Robert D. Allen III | IVVD | Common Stock | Sale | -12% | $28,004 | $1.54 | -18,189 | 133,879 | 17 Feb 2026 | Direct |
| Julie Green | IVVD | Common Stock | Sale | -13.3% | $30,273 | $1.54 | -19,663 | 128,681 | 17 Feb 2026 | Direct |
| William E. Duke | IVVD | Common Stock | Sale | -13.3% | $30,273 | $1.54 | -19,663 | 128,681 | 17 Feb 2026 | Direct |
| Timothy Edward Lee | IVVD | Common Stock | Sale | -12.4% | $30,273 | $1.54 | -19,663 | 138,681 | 17 Feb 2026 | Direct |
| Jill Andersen | IVVD | Common Stock | Sale | -13.1% | $50,454 | $1.54 | -32,771 | 216,675 | 17 Feb 2026 | Direct |
| Robert D. Allen III | IVVD | Common Stock | Options Exercise | 186.6% | 99,000 | 152,068 | 15 Feb 2026 | Direct | ||
| Robert D. Allen III | IVVD | Restricted Stock Units | Options Exercise | -49.2% | -99,000 | 102,000 | 15 Feb 2026 | Direct | ||
| Julie Green | IVVD | Common Stock | Options Exercise | 200.6% | 99,000 | 148,344 | 15 Feb 2026 | Direct | ||
| Julie Green | IVVD | Restricted Stock Units | Options Exercise | -49.2% | -99,000 | 102,000 | 15 Feb 2026 | Direct | ||
| William E. Duke | IVVD | Common Stock | Options Exercise | 200.6% | 99,000 | 148,344 | 15 Feb 2026 | Direct | ||
| William E. Duke | IVVD | Restricted Stock Units | Options Exercise | -49.2% | -99,000 | 102,000 | 15 Feb 2026 | Direct | ||
| Timothy Edward Lee | IVVD | Common Stock | Options Exercise | 166.8% | 99,000 | 158,344 | 15 Feb 2026 | Direct | ||
| Timothy Edward Lee | IVVD | Restricted Stock Units | Options Exercise | -49.2% | -99,000 | 102,000 | 15 Feb 2026 | Direct | ||
| Jill Andersen | IVVD | Common Stock | Options Exercise | 195.4% | 165,000 | 249,446 | 15 Feb 2026 | Direct | ||
| Jill Andersen | IVVD | Restricted Stock Units | Options Exercise | -49.2% | -165,000 | 170,000 | 15 Feb 2026 | Direct | ||
| Julie Green | IVVD | Stock Option (Right to Buy) | Award | 675,000 | 675,000 | 29 Jan 2026 | Direct | |||
| Timothy Edward Lee | IVVD | Stock Option (Right to Buy) | Award | 675,000 | 675,000 | 29 Jan 2026 | Direct |
* marks a reported price that did not pass the local price check.